Launch new OCS lung and heart clinical programs
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 31 Jul 2024
- Due
- 31 Dec 2025
- Delivered
- by 31 Dec 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“We remain well positioned to successfully execute our 2024 strategy and to launch our new OCS lung and heart clinical programs in 2025.”
What we found
Evidence strength A What the grades mean
The company successfully launched new clinical programs for OCS Lung and OCS Heart in 2025 by enrolling patients in two new clinical trials.
-
A TransMedics Group, Inc. 10-K filed 2026-02-24
“In 2025, we introduced next generation OCS improvements in the clinical setting for OCS Lung and OCS Heart through the enrollment of two new clinical trials.” ✓ confirmed on the page
Market reaction: the shares moved -1.1% against the S&P 500 over the three sessions around the disclosure (23 Feb 2026 to 26 Feb 2026). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- OCS lung and heart clinical programs
- In the company’s control
- Medium
- Specificity
- Medium
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you TransMedics Group, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-TMDX-001983 · Corrections policy